Skip to main content

PAINWeek 2023 Main banner

Icon Legend

This session is not in your agenda.

This session is in your agenda. Click to remove it

Back

Jennifer Madonia, MS, PA-Cx

Senior Director, Clinical Development
Biohaven Pharmaceuticals
New Haven, Connecticut

Disclosure information not submitted.

Presentation(s):

Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials
POSTER ABSTRACT